Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Harrow Health ( (HROW) ) has issued an update.
On October 6, 2025, Harrow, Inc. announced leadership changes at its subsidiary ImprimisRx, with Frank Mullery appointed as Chief Executive Officer and Bridseida Cruz as Head of Quality. These appointments are expected to drive the next phase of growth and innovation for ImprimisRx, a national leader in ophthalmic compounding, as part of Harrow’s vision to become a prominent U.S. ophthalmic company. The leadership changes are anticipated to enhance the company’s operational phase, fulfilling unmet needs of U.S. eyecare professionals and benefiting stakeholders by continuing to provide critical, affordable medicines.
The most recent analyst rating on (HROW) stock is a Buy with a $74.00 price target. To see the full list of analyst forecasts on Harrow Health stock, see the HROW Stock Forecast page.
Spark’s Take on HROW Stock
According to Spark, TipRanks’ AI Analyst, HROW is a Neutral.
Harrow Health’s overall stock score is driven by strong earnings call results and positive technical indicators, indicating growth potential. However, significant financial performance challenges and valuation concerns weigh heavily on the score. Addressing cash flow issues and improving profitability are crucial for enhancing financial stability.
To see Spark’s full report on HROW stock, click here.
More about Harrow Health
Harrow, Inc. is a leading provider of ophthalmic disease management solutions in North America, offering a comprehensive portfolio of products addressing conditions affecting both the front and back of the eye, such as dry eye disease, age-related macular degeneration, cataracts, refractive errors, and glaucoma. The company is committed to delivering safe, effective, accessible, and affordable medications to enhance patient compliance and improve clinical outcomes.
Average Trading Volume: 618,070
Technical Sentiment Signal: Strong Buy
Current Market Cap: $1.68B
See more data about HROW stock on TipRanks’ Stock Analysis page.